1. Huang FC, Chan WK, Moriarty KJ, Zhang DC, Chang MN, He W, Yu KT, Zilberstein A.. (1998) Novel cytokine release inhibitors. Part I: Triterpenes., 8 (14): [PMID:9873452] [10.1016/s0960-894x(98)00331-x] |
2. He W, Huang FC, Morytko M, Jariwala N, Yu KT.. (1998) Novel cytokine release inhibitors. Part II: Steroids., 8 (20): [PMID:9873630] [10.1016/s0960-894x(98)00521-6] |
3. He W, Huang FC, Gavai A, Chan WK, Amato G, Yu KT, Zilberstein A.. (1998) Novel cytokine release inhibitors. Part III: Truncated analogs of tripterine., 8 (24): [PMID:9934491] [10.1016/s0960-894x(98)00671-4] |
4. He W, Gavai A, Huang FC, Regan J, Hanney B, Poli G, Bruno J, Chan WK, Djuric SW, Yu KT, Zilberstein A.. (1999) Novel cytokine release inhibitors. Part IV: analogs of podocarpic acid., 9 (3): [PMID:10091704] [10.1016/s0960-894x(99)00023-2] |
5. Morita H, Hirasawa Y, Muto A, Yoshida T, Sekita S, Shirota O.. (2008) Antimitotic quinoid triterpenes from Maytenus chuchuhuasca., 18 (3): [PMID:18164197] [10.1016/j.bmcl.2007.12.016] |
6. Ngassapa O, Soejarto DD, Pezzuto JM, Farnsworth NR.. (1994) Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea., 57 (1): [PMID:8158155] [10.1021/np50103a001] |
7. Chang FR, Hayashi K, Chen IH, Liaw CC, Bastow KF, Nakanishi Y, Nozaki H, Cragg GM, Wu YC, Lee KH.. (2003) Antitumor agents. 228. five new agarofurans, Reissantins A-E, and cytotoxic principles from Reissantia buchananii., 66 (11): [PMID:14640511] [10.1021/np030241v] |
8. Figueiredo JN, Räz B, Séquin U.. (1998) Novel quinone methides from Salacia kraussii with in vitro antimalarial activity., 61 (6): [PMID:9644053] [10.1021/np9704157] |
9. Dat NT, Lee JH, Lee K, Hong YS, Kim YH, Lee JJ.. (2008) Phenolic constituents of Amorpha fruticosa that inhibit NF-kappaB activation and related gene expression., 71 (10): [PMID:18841906] [10.1021/np800383q] |
10. Jin HZ, Hwang BY, Kim HS, Lee JH, Kim YH, Lee JJ.. (2002) Antiinflammatory constituents of Celastrus orbiculatus inhibit the NF-kappaB activation and NO production., 65 (1): [PMID:11809076] [10.1021/np010428r] |
11. Lu Y, Ansar S, Michaelis ML, Blagg BS.. (2009) Neuroprotective activity and evaluation of Hsp90 inhibitors in an immortalized neuronal cell line., 17 (4): [PMID:19138859] [10.1016/j.bmc.2008.12.047] |
12. Zhou Y, Wei L, Brady TP, Murali Mohan Redddy PS, Nguyen T, Chen J, Au Q, Yoon IS, Yip G, Zhang B, Barber JR, Ng SC.. (2009) Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives as novel small molecule chaperone amplifiers., 19 (15): [PMID:19502057] [10.1016/j.bmcl.2009.05.073] |
13. Ryu YB, Park SJ, Kim YM, Lee JY, Seo WD, Chang JS, Park KH, Rho MC, Lee WS.. (2010) SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii., 20 (6): [PMID:20167482] [10.1016/j.bmcl.2010.01.152] |
14. Dat NT, Jin X, Hong YS, Lee JJ.. (2010) An isoaurone and other constituents from Trichosanthes kirilowii seeds inhibit hypoxia-inducible factor-1 and nuclear factor-kappaB., 73 (6): [PMID:20469887] [10.1021/np900820p] |
15. Sun H, Xu L, Yu P, Jiang J, Zhang G, Wang Y.. (2010) Synthesis and preliminary evaluation of neuroprotection of celastrol analogues in PC12 cells., 20 (13): [PMID:20627556] [10.1016/j.bmcl.2010.05.066] |
16. Hulot C, Peluso J, Blond G, Muller CD, Suffert J.. (2010) Synthesis of exotic polycycles such as cyclooctatrienes and fenestrenes with differential pro-apoptotic activities on human TRAIL-resistant metastatic cell lines., 20 (22): [PMID:20864342] [10.1016/j.bmcl.2010.08.094] |
17. Scott LM, Chen L, Daniel KG, Brooks WH, Guida WC, Lawrence HR, Sebti SM, Lawrence NJ, Wu J.. (2011) Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs., 21 (2): [PMID:21193311] [10.1016/j.bmcl.2010.11.117] |
18. Matts RL, Brandt GE, Lu Y, Dixit A, Mollapour M, Wang S, Donnelly AC, Neckers L, Verkhivker G, Blagg BS.. (2011) A systematic protocol for the characterization of Hsp90 modulators., 19 (1): [PMID:21129982] [10.1016/j.bmc.2010.10.029] |
19. Aoyagi Y, Adachi Y, Ozawa K, Yokomizo C, Gui MY, Jin YR, Li XW, Ohno N, Takeya K.. (2011) Synthesis of rabdokunmin C analogues and their inhibitory effect on NF-κB activation., 19 (7): [PMID:21393004] [10.1016/j.bmc.2011.02.002] |
20. Davenport J, Manjarrez JR, Peterson L, Krumm B, Blagg BS, Matts RL.. (2011) Gambogic acid, a natural product inhibitor of Hsp90., 74 (5): [PMID:21486005] [10.1021/np200029q] |
21. Cuong TD, Hung TM, Na M, Ha do T, Kim JC, Lee D, Ryoo S, Lee JH, Choi JS, Min BS.. (2011) Inhibitory effect on NO production of phenolic compounds from Myristica fragrans., 21 (22): [PMID:21978676] [10.1016/j.bmcl.2011.09.021] |
22. Park JE, Cuong TD, Hung TM, Lee I, Na M, Kim JC, Ryoo S, Lee JH, Choi JS, Woo MH, Min BS.. (2011) Alkaloids from Chelidonium majus and their inhibitory effects on LPS-induced NO production in RAW264.7 cells., 21 (23): [PMID:22024033] [10.1016/j.bmcl.2011.09.128] |
23. Nam JW, Kang GY, Han AR, Lee D, Lee YS, Seo EK.. (2011) Diarylheptanoids from the seeds of Alpinia katsumadai as heat shock factor 1 inducers., 74 (10): [PMID:21942765] [10.1021/np200355n] |
24. PubChem BioAssay data set, |
25. Johnson TA, Sohn J, Vaske YM, White KN, Cohen TL, Vervoort HC, Tenney K, Valeriote FA, Bjeldanes LF, Crews P.. (2012) Myxobacteria versus sponge-derived alkaloids: the bengamide family identified as potent immune modulating agents by scrutiny of LC-MS/ELSD libraries., 20 (14): [PMID:22705020] [10.1016/j.bmc.2012.05.043] |
26. Venkatesha SH, Astry B, Nanjundaiah SM, Yu H, Moudgil KD.. (2012) Suppression of autoimmune arthritis by Celastrus-derived Celastrol through modulation of pro-inflammatory chemokines., 20 (17): [PMID:22854193] [10.1016/j.bmc.2012.06.050] |
27. Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P.. (2012) Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine., 20 (22): [PMID:23062825] [10.1016/j.bmc.2012.09.040] |
28. Min BS, Cuong TD, Hung TM, Min BK, Shin BS, Woo MH.. (2012) Compounds from the heartwood of Caesalpinia sappan and their anti-inflammatory activity., 22 (24): [PMID:23127886] [10.1016/j.bmcl.2012.10.055] |
29. Cuong TD, Hung TM, Kim JC, Kim EH, Woo MH, Choi JS, Lee JH, Min BS.. (2012) Phenolic compounds from Caesalpinia sappan heartwood and their anti-inflammatory activity., 75 (12): [PMID:23234407] [10.1021/np3003673] |
30. Nguyen TD, Duong TT, Le TPQ, Chau VM, Le MH, Dang DK, Lee JJ, Bourguet-Kondracki M. (2011) Inhibitory effects on nuclear factor B of the Vietnamese freshwater cyanobacteria, 20 (6): [10.1007/s00044-010-9409-z] |
31. De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP.. (2013) Structure-based identification of OATP1B1/3 inhibitors., 83 (6): [PMID:23571415] [10.1124/mol.112.084152] |
32. Cuong TD, Hung TM, Lee JS, Weon KY, Woo MH, Min BS.. (2015) Anti-inflammatory activity of phenolic compounds from the whole plant of Scutellaria indica., 25 (5): [PMID:25637363] [10.1016/j.bmcl.2014.12.055] |
33. Tang WJ, Wang J, Tong X, Shi JB, Liu XH, Li J.. (2015) Design and synthesis of celastrol derivatives as anticancer agents., 95 [PMID:25812966] [10.1016/j.ejmech.2015.03.039] |
34. Hall JA, Seedarala S, Rice N, Kopel L, Halaweish F, Blagg BS.. (2015) Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery., 78 (4): [PMID:25756299] [10.1021/acs.jnatprod.5b00054] |
35. Kil YS, Choi SK, Lee YS, Jafari M, Seo EK.. (2015) Chalcones from Angelica keiskei: Evaluation of Their Heat Shock Protein Inducing Activities., 78 (10): [PMID:26431394] [10.1021/acs.jnatprod.5b00633] |
36. Jiang F, Wang HJ, Bao QC, Wang L, Jin YH, Zhang Q, Jiang D, You QD, Xu XL.. (2016) Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties., 24 (21): [PMID:27647369] [10.1016/j.bmc.2016.08.070] |
37. He Y, Wu M, Liu Y, Li Q, Li X, Hu L, Cen S, Zhou J.. (2016) Identification of Triptophenolide from Tripterygium wilfordii as a Pan-antagonist of Androgen Receptor., 7 (12): [PMID:27994731] [10.1021/acsmedchemlett.6b00180] |
38. Shan WG, Wang HG, Chen Y, Wu R, Wen YT, Zhang LW, Ying YM, Wang JW, Zhan ZJ.. (2017) Synthesis of 3- and 29-substituted celastrol derivatives and structure-activity relationship studies of their cytotoxic activities., 27 (15): [PMID:28587825] [10.1016/j.bmcl.2017.05.083] |
39. Ngo QT, Cao TQ, Tran PL, Kim JA, Seo ST, Kim JC, Woo MH, Lee JH, Min BS.. (2018) Lactones from the pericarps of Litsea japonica and their anti-inflammatory activities., 28 (11): [PMID:29730029] [10.1016/j.bmcl.2018.04.023] |
40. Figueiredo SAC, Salvador JAR, Cortés R, Cascante M.. (2017) Design, synthesis and biological evaluation of novel C-29 carbamate celastrol derivatives as potent and selective cytotoxic compounds., 139 [PMID:28865279] [10.1016/j.ejmech.2017.08.058] |
41. Wang L, Li L, Zhou ZH, Jiang ZY, You QD, Xu XL.. (2017) Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction., 136 [PMID:28482218] [10.1016/j.ejmech.2017.04.074] |
42. Bodle CR, Mackie DI, Hayes MP, Schamp JH, Miller MR, Henry MD, Doorn JA, Houtman JCD, James MA, Roman DL.. (2017) Natural Products Discovered in a High-Throughput Screen Identified as Inhibitors of RGS17 and as Cytostatic and Cytotoxic Agents for Lung and Prostate Cancer Cell Lines., 80 (7): [PMID:28621943] [10.1021/acs.jnatprod.7b00112] |
43. Figueiredo SAC, Salvador JAR, Cortés R, Cascante M.. (2017) Novel celastrol derivatives with improved selectivity and enhanced antitumour activity: Design, synthesis and biological evaluation., 138 [PMID:28688281] [10.1016/j.ejmech.2017.06.029] |
44. Choi SK, Mun GI, Choi E, Kim SY, Kwon Y, Na Y, Lee YS.. (2017) The Conjugated Double Bond of Coniferyl Aldehyde Is Essential for Heat Shock Factor 1 Mediated Cytotoprotection., 80 (8): [PMID:28737916] [10.1021/acs.jnatprod.7b00126] |
45. Liu N, Tu J, Dong G, Wang Y, Sheng C.. (2018) Emerging New Targets for the Treatment of Resistant Fungal Infections., 61 (13): [PMID:29294275] [10.1021/acs.jmedchem.7b01413] |
46. Jin L, Huang R, Huang X, Zhang B, Ji M, Wang H.. (2018) Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance., 26 (8): [PMID:29486954] [10.1016/j.bmc.2018.02.021] |
47. Salvador JAR, Leal AS, Valdeira AS, Gonçalves BMF, Alho DPS, Figueiredo SAC, Silvestre SM, Mendes VIS.. (2017) Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment., 142 [PMID:28754470] [10.1016/j.ejmech.2017.07.013] |
48. Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper. CO-ADD screening of NIH NCI Diversity Set V, [10.6019/CHEMBL4296182] |
49. Li N, Xu M, Bao N, Shi W, Li Q, Zhang X, Sun J, Chen L.. (2018) Discovery of novel NO-releasing celastrol derivatives with Hsp90 inhibition and cytotoxic activities., 160 [PMID:30316059] [10.1016/j.ejmech.2018.10.013] |
50. Li X, Ding J, Li N, Liu W, Ding F, Zheng H, Ning Y, Wang H, Liu R, Ren S.. (2019) Synthesis and biological evaluation of celastrol derivatives as anti-ovarian cancer stem cell agents., 179 [PMID:31279299] [10.1016/j.ejmech.2019.06.086] |
51. Kyriakou E, Schmidt S, Dodd GT, Pfuhlmann K, Simonds SE, Lenhart D, Geerlof A, Schriever SC, De Angelis M, Schramm KW, Plettenburg O, Cowley MA, Tiganis T, Tschöp MH, Pfluger PT, Sattler M, Messias AC.. (2018) Celastrol Promotes Weight Loss in Diet-Induced Obesity by Inhibiting the Protein Tyrosine Phosphatases PTP1B and TCPTP in the Hypothalamus., 61 (24): [PMID:30525586] [10.1021/acs.jmedchem.8b01224] |
52. Li N, Xu M, Wang B, Shi Z, Zhao Z, Tang Y, Wang X, Sun J, Chen L.. (2019) Discovery of Novel Celastrol Derivatives as Hsp90-Cdc37 Interaction Disruptors with Antitumor Activity., 62 (23): [PMID:31725288] [10.1021/acs.jmedchem.9b01290] |
53. Stevens M, Abdeen S, Salim N, Ray AM, Washburn A, Chitre S, Sivinski J, Park Y, Hoang QQ, Chapman E, Johnson SM.. (2019) HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules., 29 (9): [PMID:30852084] [10.1016/j.bmcl.2019.02.028] |
54. Xu M, Li N, Zhao Z, Shi Z, Sun J, Chen L.. (2019) Design, synthesis and antitumor evaluation of novel celastrol derivatives., 174 [PMID:31051401] [10.1016/j.ejmech.2019.04.050] |
55. Chen Z, Zhang D, Yan S, Hu C, Huang Z, Li Z, Peng S, Li X, Zhu Y, Yu H, Lian B, Kang Q, Li M, Zeng Z, Zhang XK, Su Y.. (2019) SAR study of celastrol analogs targeting Nur77-mediated inflammatory pathway., 177 [PMID:31132532] [10.1016/j.ejmech.2019.05.009] |
56. Li L, Wang L, You QD, Xu XL.. (2020) Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions., 63 (5): [PMID:31663736] [10.1021/acs.jmedchem.9b00940] |
57. (2016) Therapeutic compounds and methods, |
58. (2018) INHIBITORS OF SARM1 NADase ACTIVITY AND USES THEREOF, |
59. He QW,Feng JH,Hu XL,Long H,Huang XF,Jiang ZZ,Zhang XQ,Ye WC,Wang H. (2020) Synthesis and Biological Evaluation of Celastrol Derivatives as Potential Immunosuppressive Agents., 83 (9.0): [PMID:32822186] [10.1021/acs.jnatprod.0c00067] |
60. Li B,Yao J,Guo K,He F,Chen K,Lin Z,Liu S,Huang J,Wu Q,Fang M,Zeng J,Wu Z. (2020) Design, synthesis, and biological evaluation of 5-((8-methoxy-2-methylquinolin-4-yl)amino)-1H-indole-2-carbohydrazide derivatives as novel Nur77 modulators., 204 [PMID:32717483] [10.1016/j.ejmech.2020.112608] |
61. Capochiani de Iudicibus R, Tomek P, Palmer BD, Tijono SM, Flanagan JU, Ching LM.. (2021) Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay., 39 [PMID:33901770] [10.1016/j.bmc.2021.116160] |
62. Linciano P, Cavalloro V, Martino E, Kirchmair J, Listro R, Rossi D, Collina S.. (2020) Tackling Antimicrobial Resistance with Small Molecules Targeting LsrK: Challenges and Opportunities., 63 (24.0): [PMID:33152241] [10.1021/acs.jmedchem.0c01282] |
63. Shang FF, Wang JY, Xu Q, Deng H, Guo HY, Jin X, Li X, Shen QK, Quan ZS.. (2021) Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway., 220 [PMID:33930802] [10.1016/j.ejmech.2021.113474] |
64. Coghi P, Ng JPL, Kadioglu O, Law BYK, Qiu AC, Saeed MEM, Chen X, Ip CK, Efferth T, Liu L, Wong VKW.. (2021) Synthesis, computational docking and biological evaluation of celastrol derivatives as dual inhibitors of SERCA and P-glycoprotein in cancer therapy., 224 [PMID:34256125] [10.1016/j.ejmech.2021.113676] |
65. Munoz-Tello P, Lin H, Khan P, de Vera IMS, Kamenecka TM, Kojetin DJ.. (2020) Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1., 63 (24.0): [PMID:33289551] [10.1021/acs.jmedchem.0c00894] |
66. Feng Y, Wang W, Zhang Y, Fu X, Ping K, Zhao J, Lei Y, Mou Y, Wang S.. (2022) Synthesis and biological evaluation of celastrol derivatives as potential anti-glioma agents by activating RIP1/RIP3/MLKL pathway to induce necroptosis., 229 [PMID:34968902] [10.1016/j.ejmech.2021.114070] |
67. Zhao J, Xiao R, Zeng R, He E, Zhang A.. (2022) Small molecules targeting cGAS-STING pathway for autoimmune disease., 238 [PMID:35635952] [10.1016/j.ejmech.2022.114480] |
68. Song Y, Wang S, Zhao M, Yang X, Yu B.. (2022) Strategies Targeting Protein Tyrosine Phosphatase SHP2 for Cancer Therapy., 65 (4.0): [PMID:35157464] [10.1021/acs.jmedchem.1c02008] |
69. Fu X, Mao Q, Zhang B, Lv J, Ping K, Zhang P, Lin F, Zhao J, Feng Y, Yang J, Wang H, Zhang L, Mou Y, Wang S.. (2022) Thiazolidinedione-Based Structure Modification of Celastrol Provides Thiazolidinedione-Conjugated Derivatives as Potent Agents against Non-Small-Cell Lung Cancer Cells through a Mitochondria-Mediated Apoptotic Pathway., 85 (4.0): [PMID:35255689] [10.1021/acs.jnatprod.2c00104] |
70. Lei ZC, Li N, Yu NR, Ju W, Sun XN, Zhang XL, Dong HJ, Sun JB, Chen L.. (2022) Design and Synthesis of Novel Celastrol Derivatives as Potential Anticancer Agents against Gastric Cancer Cells., 85 (5.0): [PMID:35536757] [10.1021/acs.jnatprod.1c01236] |
71. Chang YH, Hung HY.. (2022) Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review., 237 [PMID:35489224] [10.1016/j.ejmech.2022.114405] |
72. Feng Y, Zhang B, Lv J, Zhang P, Mao Q, Lin F, Zhao J, Fu X, Yang Y, Li Z, Zhang L, Mou Y, Wang S.. (2022) Scaffold hopping of celastrol provides derivatives containing pepper ring, pyrazine and oxazole substructures as potent autophagy inducers against breast cancer cell line MCF-7., 234 [PMID:35290844] [10.1016/j.ejmech.2022.114254] |
73. Hicks EG, Kandel SE, Lampe JN.. (2022) Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (Mpro) inhibitors., 66 [PMID:35427739] [10.1016/j.bmcl.2022.128732] |
74. Li N, Xu M, Zhang L, Lei Z, Chen C, Zhang T, Chen L, Sun J.. (2022) Discovery of Novel Celastrol-Imidazole Derivatives with Anticancer Activity In Vitro and In Vivo., 65 (6.0): [PMID:35238566] [10.1021/acs.jmedchem.1c01293] |
75. Willems S, Zaienne D, Merk D.. (2021) Targeting Nuclear Receptors in Neurodegeneration and Neuroinflammation., 64 (14.0): [PMID:34251209] [10.1021/acs.jmedchem.1c00186] |
76. Hu XL, He QW, Long H, Zhang LX, Wang R, Wang BL, Feng JH, Wang Q, Hou JQ, Zhang XQ, Ye WC, Wang H.. (2021) Synthesis and Biological Evaluation of Celastrol Derivatives with Improved Cytotoxic Selectivity and Antitumor Activities., 84 (7.0): [PMID:34170694] [10.1021/acs.jnatprod.1c00262] |
77. Hou W, Liu B, Xu H.. (2020) Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology., 189 [PMID:31991334] [10.1016/j.ejmech.2020.112081] |
78. Qin J, Chen X, Liu W, Chen J, Liu W, Xia Y, Li Z, Li M, Wang S, Yuan Q, Qiu Y, Wu Z, Fang M.. (2022) Discovery of 5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1H-indole-2-carboxamide derivatives as novel anti-cancer agents targeting Nur77., 244 [PMID:36274272] [10.1016/j.ejmech.2022.114849] |
79. Kumar V, Islam A, Hassan MI, Ahmad F.. (2016) Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning., 121 [PMID:27372371] [10.1016/j.ejmech.2016.06.017] |